Free Trial

Astera Labs (NASDAQ:ALAB) Sets New 52-Week High - Still a Buy?

Astera Labs logo with Computer and Technology background

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares hit a new 52-week high on Wednesday . The stock traded as high as $117.26 and last traded at $116.51, with a volume of 8290921 shares. The stock had previously closed at $103.39.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on ALAB. Roth Mkm increased their target price on Astera Labs from $80.00 to $105.00 and gave the stock a "buy" rating in a research report on Tuesday, November 5th. Needham & Company LLC reaffirmed a "buy" rating and issued a $65.00 target price on shares of Astera Labs in a research report on Wednesday, October 9th. Morgan Stanley increased their price target on Astera Labs from $74.00 to $94.00 and gave the company an "overweight" rating in a report on Tuesday, November 5th. Barclays increased their price target on Astera Labs from $70.00 to $87.00 and gave the company an "overweight" rating in a report on Tuesday, November 5th. Finally, Stifel Nicolaus increased their price target on Astera Labs from $80.00 to $100.00 and gave the company a "buy" rating in a report on Tuesday, November 5th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $94.67.

Check Out Our Latest Analysis on Astera Labs

Astera Labs Stock Down 1.1 %

The stock's fifty day simple moving average is $77.58 and its 200-day simple moving average is $61.40.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.06. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm had revenue of $113.10 million for the quarter, compared to analysts' expectations of $97.50 million. The company's quarterly revenue was up 47.1% compared to the same quarter last year. On average, equities analysts expect that Astera Labs, Inc. will post -0.45 EPS for the current fiscal year.

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 50,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $89.70, for a total transaction of $4,485,000.00. Following the sale, the director now owns 129,617 shares of the company's stock, valued at approximately $11,626,644.90. The trade was a 27.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Sanjay Gajendra sold 740,000 shares of the firm's stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $96.59, for a total transaction of $71,476,600.00. Following the transaction, the insider now owns 775,000 shares in the company, valued at $74,857,250. This represents a 48.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,897,820 shares of company stock valued at $168,252,298.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ALAB. Hollencrest Capital Management acquired a new position in Astera Labs in the third quarter worth approximately $26,000. US Bancorp DE purchased a new position in Astera Labs during the 3rd quarter worth approximately $46,000. First Horizon Advisors Inc. purchased a new position in Astera Labs during the 3rd quarter worth approximately $49,000. Allworth Financial LP grew its position in Astera Labs by 445.5% during the 3rd quarter. Allworth Financial LP now owns 1,091 shares of the company's stock worth $57,000 after purchasing an additional 891 shares in the last quarter. Finally, Amalgamated Bank purchased a new position in Astera Labs during the 2nd quarter worth approximately $74,000.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Articles

Should you invest $1,000 in Astera Labs right now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines